A

Acadia Pharmaceuticals

Develops and commercializes CNS disorder therapies

Senior Medical Director

Biology & BiotechConfirmed live in the last 24 hours
Full-timeMunich, GermanyNo salary listed

About the Job

Requirements

  • At least 15 years of Medical Affairs leadership experience in the biopharmaceutical industry in Germany or the DACH region; broader regional experience is advantageous.
  • Prior team-management experience is required.
  • Substantial rare-disease experience, preferably neurological, in Germany and/or the DACH region.
  • Extensive knowledge of the German healthcare system and applicable national rules and regulations.
  • Significant experience coordinating and participating in national MLR/MRC procedures.
  • Extensive knowledge to critically appraise studies and clinical evidence and engage with healthcare professionals at a higher scientific level.
  • In-depth understanding of compliance and regulatory requirements for pharmaceutical Medical Affairs, R&D, and Commercial activities in Germany, including personal expertise with MRC/MLR procedures.
  • Fluency in German at native or near-native level and strong English proficiency are required.
  • Ability to travel locally and internationally.

Responsibilities

  • Provide scientific and medical leadership, including developing strategic country medical affairs post-launch plans and identifying unmet medical needs and data gaps.
  • Lead the local medical affairs team.
  • Ensure strong medical/scientific leadership in coordination with and participation in country MRC/MLR procedures.
  • Establish appropriate strategic partnerships with Centers of Excellence, key opinion leaders, and patient advocacy groups in areas of scientific interest.
  • Collaborate closely with the country general manager, Market Access, and relevant country and international staff to manage relationships and ensure alignment and effective execution of the German medical strategy.
  • Coordinate operational medical excellence with EU medical teams and align with country strategy to capture and track key medical tactics and post-launch medical activities in Germany.
  • Provide medical expertise and editorial support for disseminating data at conferences and in medical journals, as appropriate.
  • Engage key healthcare professionals in scientific and medical information exchange, including advisory boards and presentations at national meetings and conferences.
  • Develop and maintain close professional relationships with key opinion leaders and emerging scientific leaders in the community, together with Medical Science Liaisons.
  • Oversee gathering and reporting field medical insights through the Veeva CRM system in line with company rules and requirements.
  • Communicate Medical Science Liaison team insights about the competitive landscape and unmet needs of physicians and advocacy groups to cross-functional stakeholders, and develop potential actionable plans to address local insights.
  • Manage publication activities, including reviewing and approving abstracts and manuscripts, developing local publication strategy and real-world evidence, and collaborating compliantly with authors as needed.
  • Collaborate and share information to contribute to planning and execute the agreed local Medical pre-launch or launch plan with the Medical Science Liaison team, in line with Regional Medical Affairs strategy.

Desired Qualifications

  • A medical degree is highly preferred; a PhD, PharmD, or equivalent qualification may also be considered.
  • Broader regional experience beyond Germany or the DACH region is advantageous.
  • Experience engaging with rare-disease patient advocacy groups is highly preferred.

About the Company

Acadia Pharmaceuticals

Develops and commercializes CNS disorder therapies

ACADIA Pharmaceuticals develops and commercializes medicines for central nervous system (CNS) disorders, focusing on neurological and psychiatric conditions with unmet medical needs. Its work centers on identifying drug candidates, advancing them through preclinical and clinical trials, and, upon regulatory approval, bringing therapies to market. Its products address CNS conditions such as Parkinson's disease psychosis, reflecting a commitment to treating complex brain disorders. The company combines in-house research with potential strategic collaborations to expand its portfolio and reach. Unlike peers that rely on a single development path, ACADIA emphasizes a broad pipeline and the ability to commercialize approved therapies, aiming to provide effective CNS treatments to patients and improve outcomes in mental health and neuroscience.

Company size
1,001-5,000
Company stage
IPO
Headquarters
San Diego, CA
Founded
1993

Recently Posted Jobs

Explore more opportunities at Acadia Pharmaceuticals

See more jobs